TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 139 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q2 2017. The put-call ratio across all filers is 6.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $112,000 | -5.9% | 1,132 | 0.0% | 0.01% | -10.0% |
| Q4 2017 | $119,000 | -65.4% | 1,132 | -62.9% | 0.01% | -74.4% |
| Q3 2017 | $344,000 | -43.9% | 3,052 | -44.2% | 0.04% | -51.2% |
| Q2 2017 | $613,000 | -2.1% | 5,474 | +2.0% | 0.08% | -12.1% |
| Q1 2017 | $626,000 | -1.1% | 5,369 | -6.3% | 0.09% | -23.5% |
| Q3 2016 | $633,000 | -21.2% | 5,729 | +3.9% | 0.12% | -35.0% |
| Q2 2016 | $803,000 | +1.9% | 5,512 | +0.2% | 0.18% | -14.9% |
| Q1 2016 | $788,000 | -7.3% | 5,502 | 0.0% | 0.22% | -21.2% |
| Q4 2015 | $850,000 | -0.9% | 5,502 | -8.3% | 0.27% | +5.4% |
| Q3 2015 | $858,000 | – | 6,002 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 78,905 | $8,306,000 | 7.65% |
| FORT, L.P. | 157,584 | $16,589,000 | 4.68% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 808,200 | $85,079,000 | 4.39% |
| Strategic Global Advisors, LLC | 81,432 | $8,572,000 | 3.18% |
| Prince Street Capital Management LLC | 48,700 | $5,127,000 | 1.62% |
| Analyst IMS Investment Management Services Ltd. | 31,438 | $3,309,000 | 1.45% |
| Freestone Capital Holdings, LLC | 84,900 | $8,937,000 | 0.77% |
| RPG Investment Advisory, LLC | 17,227 | $1,813,000 | 0.61% |
| CLINTON GROUP INC | 46,370 | $4,881,000 | 0.28% |
| USA FINANCIAL FORMULAS | 10,786 | $1,135,000 | 0.28% |